±³È¸¿ëǰ´ëÇ¥ ºê·£µå `¿òÅÍ`
ÁÁÀº±Û
¿òÅ͹°Æ¼½´´Â ±ú²ýÇÏ°í ¾ÈÀüÇÕ¡¦
¹Ù´ÙÀ̾߱â´Ù¿î·Îµå ¡ô 15.rbh¡¦
»ç¾Æ´ÙÄð ¢Ô 35.ruq934.top ¢Ç¡¦
¸±°ÔÀÓ°ñµå¸ù ¨¿ 48.rbh443.to¡¦
 
ÀÛ¼ºÀÏ : 21-11-30 22:43
¸ÓÅ©(Merck) ÄÚºñµå-19 Ä¡·áÁ¦ ÀÔ¿ø ¹× »ç¸Á ¹æÁöÈ¿°ú°¡ ÀÌÀüº¸´Ù ³·Àº °ÍÀ¸·Î º¸°í
 ±Û¾´ÀÌ :
Á¶È¸ : 20  

http://www.reuters.com/business/healthcare-pharmaceuticals/merck-says-covid-19-pill-cuts-hospitalization-death-risk-by-30-2021-11-26/


Nov 26 (Reuters) Merck & Co (MRK.N) said on Friday updated data from its study on its experimental COVID-19 pill showed the drug was less effective in cutting hospitalizations and deaths than previously reported.


11¿ù 26ÀÏ (·ÎÀÌÅÍ) ¸ÓÅ© & Co (MRK.N)´Â À̹ø ±Ý¿äÀÏ ÇöÀç ½ÇÇè Áß¿¡ ÀÖ´Â COVID-19 Ä¡·áÁ¦¿¡ ´ëÇÑ ¿¬±¸ ¾÷µ¥ÀÌÆ®¿¡¼­ "µ¥ÀÌÅÍ¿¡ ¾à¹°ÀÌ ÀÔ¿ø ¹× »ç¸ÁÀ» ¹æÁöÇϴµ¥ ÀÖ¾î ÀÌÀü¿¡ ¹ßÇ¥µÇ¾ú´ø ÀڷẸ´Ù È¿°ú°¡ Àû¾ú´Ù"°í ¸»Çß´Ù.


The drugmaker said its pill showed a 30% reduction in hospitalizations and deaths, based on data from over 1,400 patients. In October, its data showed a roughly 50% efficacy, based on data from 775 patients.


ÀÌ Á¦¾à ȸ»ç´Â 1,400¸í ÀÌ»óÀÇ È¯ÀڷκÎÅÍÀÇ µ¥ÀÌÅ͸¦ Åä´ë·Î ¾àÀÌ ÀÔ¿ø°ú »ç¸ÁÀÌ 30% °¨¼ÒÇÏ´Â È¿°ú¸¦ º¸¿´´Ù°í ¹àÇû´Ù. Áö³­ 10¿ù¿¡ ¹ßÇ¥µÈ µ¥ÀÌÅÍ¿¡ µû¸£¸é ÀÌ Ä¡·áÁ¦´Â 775¸íÀÇ È¯ÀÚÀÇ ÀÚ·á¿¡¼­ 50%ÀÇ È¿°ú¸¦ º¸¿´´Ù.


 
   

¾ÆÀ̵ð : woomter    ÆÐ½º¿öµå : 1250